405 related articles for article (PubMed ID: 31468993)
21. Prevalence and determinants of non-communicable diseases including depression among HIV patients on antiretroviral therapy in Dar es Salaam, Tanzania.
Mutagonda RF; Siril H; Kaaya S; Amborose T; Haruna T; Mhalu A; Urassa D; Mtisi E; Moshiro C; Tarimo E; Mahiti GR; Minja A; Somba M; August F; Mugusi F
Trop Med Int Health; 2022 Aug; 27(8):742-751. PubMed ID: 35687423
[TBL] [Abstract][Full Text] [Related]
22. A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe.
Magodoro IM; Esterhuizen TM; Chivese T
BMC Res Notes; 2016 Aug; 9():379. PubMed ID: 27484005
[TBL] [Abstract][Full Text] [Related]
23. Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study.
Amberbir A; Banda V; Singano V; Matengeni A; Pfaff C; Ismail Z; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
PLoS One; 2019; 14(1):e0210629. PubMed ID: 30653539
[TBL] [Abstract][Full Text] [Related]
24. Hematologic alterations and early mortality in a cohort of HIV positive African patients.
Ciccacci F; Lucaroni F; Latagliata R; Morciano L; Mondlane E; Balama M; Tembo D; Gondwe J; Orlando S; Palombi L; Marazzi MC
PLoS One; 2020; 15(11):e0242068. PubMed ID: 33170905
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda.
Kansiime S; Mwesigire D; Mugerwa H
PLoS One; 2019; 14(8):e0221022. PubMed ID: 31398244
[TBL] [Abstract][Full Text] [Related]
26. Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil.
Castilho JL; Escuder MM; Veloso V; Gomes JO; Jayathilake K; Ribeiro S; Souza RA; Ikeda ML; de Alencastro PR; Tupinanbas U; Brites C; McGowan CC; Grangeiro A; Grinsztejn B
J Int AIDS Soc; 2019 Jan; 22(1):e25233. PubMed ID: 30697950
[TBL] [Abstract][Full Text] [Related]
27. Non-communicable diseases in older people living with HIV in four African countries: a cohort study.
Chang D; Esber A; Dear N; Iroezindu M; Bahemana E; Kibuuka H; Owuoth J; Maswai J; Crowell T; Polyak C; Cavanaugh JS; Ake JA; Godfrey C
Lancet HIV; 2022 Mar; 9 Suppl 1():S5. PubMed ID: 35304847
[TBL] [Abstract][Full Text] [Related]
28. Systematic Review of Hypertension and Diabetes Burden, Risk Factors, and Interventions for Prevention and Control in Malawi: The NCD BRITE Consortium.
Amberbir A; Lin SH; Berman J; Muula A; Jacoby D; Wroe E; Maliwichi-Nyirenda C; Mwapasa V; Crampin A; Makwero M; Singogo E; Phiri S; Gordon S; Tobe SW; Masiye J; Newsome B; Hosseinipour M; Nyirenda MJ; van Oosterhout JJ
Glob Heart; 2019 Jun; 14(2):109-118. PubMed ID: 31324364
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study.
Ekrikpo UE; Akpan EE; Ekott JU; Bello AK; Okpechi IG; Kengne AP
BMJ Open; 2018 Jul; 8(7):e019664. PubMed ID: 30030310
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
Bonjoch A; Juega J; Puig J; Pérez-Alvarez N; Aiestarán A; Echeverría P; Pérez V; Clotet B; Romero R; Bonet J; Negredo E
AIDS Patient Care STDS; 2014 Oct; 28(10):524-9. PubMed ID: 25238104
[TBL] [Abstract][Full Text] [Related]
31. Novel approaches to screening for noncommunicable diseases: Lessons from Neno, Malawi.
Kachimanga C; Cundale K; Wroe E; Nazimera L; Jumbe A; Dunbar E; Kalanga N
Malawi Med J; 2017 Jun; 29(2):78-83. PubMed ID: 28955411
[TBL] [Abstract][Full Text] [Related]
32. Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
Maggi P; De Socio GV; Menzaghi B; Molteni C; Squillace N; Taramasso L; Guastavigna M; Gamboni G; Madeddu G; Vichi F; Cascio A; Sarchi E; Pellicanò G; Martinelli CV; Celesia BM; Valsecchi L; Gulminetti R; Cenderello G; Parisini A; Calza L; Falasca K; Orofino G; Ricci E; Di Biagio A; Bonfanti P
BMC Infect Dis; 2022 Sep; 22(1):745. PubMed ID: 36151508
[TBL] [Abstract][Full Text] [Related]
33. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
[TBL] [Abstract][Full Text] [Related]
34. Does Engagement in HIV Care Affect Screening, Diagnosis, and Control of Noncommunicable Diseases in Sub-Saharan Africa? A Systematic Review and Meta-analysis.
Kileel EM; Zheng A; Bor J; Fox MP; Crowther NJ; George JA; Khoza S; Rosen S; Venter WDF; Raal F; Hibberd P; Brennan AT
AIDS Behav; 2024 Feb; 28(2):591-608. PubMed ID: 38300475
[TBL] [Abstract][Full Text] [Related]
35. Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study.
Serrão R; Piñero C; Velez J; Coutinho D; Maltez F; Lino S; Sarmento E Castro R; Tavares AP; Pacheco P; Lopes MJ; Mansinho K; Miranda AC; Neves I; Correia de Abreu R; Almeida J; Pássaro L
Int J Infect Dis; 2019 Feb; 79():94-100. PubMed ID: 30529370
[TBL] [Abstract][Full Text] [Related]
36. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
37. Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort.
Bonnet F; Le Marec F; Leleux O; Gerard Y; Neau D; Lazaro E; Duffau P; Caubet O; Vandenhende MA; Mercie P; Cazanave C; Dabis F
BMC Infect Dis; 2020 Nov; 20(1):850. PubMed ID: 33198667
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
39. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
Fontela C; Castilla J; Juanbeltz R; Martínez-Baz I; Rivero M; O'Leary A; Larrea N; San Miguel R
Postgrad Med; 2018 Apr; 130(3):317-324. PubMed ID: 29486621
[TBL] [Abstract][Full Text] [Related]
40. Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.
Page ID; McKew SJ; Kudzala AG; Fullwood C; van Oosterhout JJ; Bates I
Int J STD AIDS; 2013 Jun; 24(6):449-53. PubMed ID: 23970747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
